NCT05412433Active, not recruiting
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
Source: ClinicalTrials.gov · Last updated 26 Jan 2026
Brief summary (registry, in English)
Hybrid Type II effectiveness-implementation trial to investigate whether electronic medical and sexual history data collection with HIV risk categorization/scoring will increase pre-exposure prophylaxis (PrEP) uptake among cis-gender women attending routine well-woman gynecologic preventative visits.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 1170 (estimated)
- First submitted
- 2 Jun 2022
- Start date
- 3 Oct 2022
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- Johns Hopkins University
- Diseases
- HIV
- NCT number
- NCT05412433
What you commit to
- Study type: Interventional
- Planned participants: 1170
- From 3 Oct 2022 to the primary completion date, 31 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Living with HIV
Other
- Pregnant and has established prenatal care, i.e., visit is for prenatal care
- Non-English or non-Spanish speaking
- Unable to complete the eHxForm
Who the study is looking for
- Patients of enrolled providers aged 15-65 years
- Presenting for preventive care (i.e., well-woman exam, sexually transmitted infection testing, pre-conception counseling, or birth control).
Age in the registry: 15 years to 65 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins Health System Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.